Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
Kai Tang, Yahong Wu, Yihui Song, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 253

Showing 1-25 of 253 citing articles:

The hallmarks of cancer metabolism: Still emerging
Natalya N. Pavlova, Jiajun Zhu, Craig B. Thompson
Cell Metabolism (2022) Vol. 34, Iss. 3, pp. 355-377
Open Access | Times Cited: 787
Cancer vaccines: the next immunotherapy frontier
Matthew J. Lin, Judit Svensson‐Arvelund, Gabrielle S. Lubitz, et al.
Nature Cancer (2022) Vol. 3, Iss. 8, pp. 911-926
Closed Access | Times Cited: 568
A timeline of tumour-associated macrophage biology
Luca Cassetta, Jeffrey W. Pollard
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 238-257
Closed Access | Times Cited: 275
Myeloid cell-targeted therapies for solid tumours
Sangeeta Goswami, Swetha Anandhan, Deblina Raychaudhuri, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 106-120
Closed Access | Times Cited: 142
Harnessing Nanomaterials for Cancer Sonodynamic Immunotherapy
Shuang Liang, Jianjun Yao, Dan Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 123
Therapeutic targeting of regulatory T cells in cancer
Feng Shan, Ashwin Somasundaram, Tullia C. Bruno, et al.
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 944-961
Open Access | Times Cited: 115
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity
Yuheng Yan, Lan Huang, Yiming Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 108
Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis
Winnie Fong, Qing Li, Fenfen Ji, et al.
Gut (2023) Vol. 72, Iss. 12, pp. 2272-2285
Open Access | Times Cited: 89
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy
Ping Huang, Yao Yang, Wenyan Wang, et al.
Biomaterials (2023) Vol. 299, pp. 122157-122157
Closed Access | Times Cited: 58
Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization
Wenying Wang, Tianran Li, Yue Cheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 5, pp. 815-832.e12
Open Access | Times Cited: 45
CD8+ T cell-based cancer immunotherapy
Yanxia Chen, Dingning Yu, Hui Qian, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 19
A metabolic dependency of EBV can be targeted to hinder B cell transformation
Bojana Müller-Durovic, J. Jäger, Christine Engelmann, et al.
Science (2024) Vol. 385, Iss. 6704
Closed Access | Times Cited: 16
Preoperative Peripheral Blood Serotonin and Kynurenine Levels Are Associated With Oncological Outcomes in Glioblastoma IDH-wt Patients
Silvia Snider, Filippo Gagliardi, Pierfrancesco De Domenico, et al.
International Journal of Tryptophan Research (2025) Vol. 18
Open Access | Times Cited: 2
Tumor Microenvironment—A Short Review of Cellular and Interaction Diversity
Aleksandra Bożyk, Kamila Wojas‐Krawczyk, Paweł Krawczyk, et al.
Biology (2022) Vol. 11, Iss. 6, pp. 929-929
Open Access | Times Cited: 67
An in situ hydrogel-mediated chemo-immunometabolic cancer therapy
Bo Wang, Jing Chen, Julia S. Caserto, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma
Richard P. Tobin, Dasha T. Cogswell, Victoria M. Cates, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 7, pp. 1209-1219
Closed Access | Times Cited: 53
Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
Qi Shang, Yabing Dong, Yun Su, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114308-114308
Closed Access | Times Cited: 50
Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs
André E. Nel, Kuo‐Ching Mei, Yu‐Pei Liao, et al.
ACS Nano (2022) Vol. 16, Iss. 4, pp. 5184-5232
Open Access | Times Cited: 45
Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
Bayley McRitchie, Billur Akkaya
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Yinan Ding, Luhong Wang, Han Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Tryptophan metabolism and disposition in cancer biology and immunotherapy
Abdulla A.‐B. Badawy
Bioscience Reports (2022) Vol. 42, Iss. 11
Open Access | Times Cited: 41
Strategies to overcome DC dysregulation in the tumor microenvironment
Guillaume Mestrallet, Kazuki Sone, Nina Bhardwaj
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top